KIT and neoplasm: Similarly, pharmacologic inhibition of c-kit with imatinib attenuated PNF growth in Nf1flox/-; Krox20Cre [86] and Nf1flox/flox;PostnCre mice [98] and resulted in volumetric tumor reduction in a subset of PNF in a subsequent phase 1–2 clinical trial [99].